95 related articles for article (PubMed ID: 18079623)
21. [Combination of irinotecan and Mitomycin C as second-line chemotherapy for patients with unresectable advanced or recurrent gastric cancer in clinical practice].
Miyamoto H; Yoshida M; Yamanouchi T; Kanda K; Zinnouchi K; Kiyozumi T; Koba I; Akashi R; Sagara K
Gan To Kagaku Ryoho; 2009 Aug; 36(8):1293-7. PubMed ID: 19692768
[TBL] [Abstract][Full Text] [Related]
22. [Clinical efficacy of low-dose CDDP and CPT-11 therapy as second- or third-line chemotherapy for advanced and recurrent gastric cancer].
Ito S; Takagawa R; Minami Y; Watanabe J; Morita T; Mogaki M; Masui H
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1107-11. PubMed ID: 25248893
[TBL] [Abstract][Full Text] [Related]
23. Activity and safety of a low dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin for relapsed gastric cancer patients: a preliminary report.
Shimoyama S; Aoki F; Shimizu N; Tatsutomi Y; Mafune K; Kaminishi M
Int J Clin Oncol; 2003 Feb; 8(1):49-52. PubMed ID: 12601543
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of irinotecan plus leucovorin and bolus 5-fluorouracil as first- or second-line chemotherapy in patients with advanced gastric or esophageal-gastric junction adenocarcinoma.
Koutras AK; Gerolymos MK; Kontogeorgou E; Iconomou G; Vourli G; Tsiata E; Makatsoris T; Chrysanthopoulos C; Kalofonos HP
J Chemother; 2007 Dec; 19(6):724-30. PubMed ID: 18230557
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of irinotecan combined with cisplatin by divided administration in patients with untreated primary non-small cell lung cancer].
Asano T; Namikawa O; Yamamoto A; Sano T; Mukai J; Kawaji K; Kobayashi M
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):771-5. PubMed ID: 9866979
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer.
Rosati G; Tucci A; Rinaldi A; Colarusso D; Pizza C; Reggiardo G; Manzione L
Oncology; 2004; 66(5):371-8. PubMed ID: 15331924
[TBL] [Abstract][Full Text] [Related]
27. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial].
Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K
Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer.
Jeung HC; Rha SY; Noh SH; Roh JK; Chung HC
Cancer Chemother Pharmacol; 2007 Feb; 59(3):313-20. PubMed ID: 16770582
[TBL] [Abstract][Full Text] [Related]
29. Preliminary study of fortnightly irinotecan hydrochloride plus cisplatin therapy in patients with advanced gastric and colorectal cancer.
Sato A; Kurihara M; Matsukawa M; Shimada K; Yamazaki T; Nakamachi M; Koda T
Cancer Chemother Pharmacol; 2001 May; 47(5):380-4. PubMed ID: 11391851
[TBL] [Abstract][Full Text] [Related]
30. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
[TBL] [Abstract][Full Text] [Related]
32. [Successful downstaging by a low-dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin in peritoneal lavage cytology positive, 5-fluorouracil refractory advanced gastric cancer patients].
Shimoyama S; Imamura K; Katayama A; Hiki N; Shimizu N; Yamaguchi H; Mafune K; Motoi T; Oohashi K; Kaminishi M
Gan To Kagaku Ryoho; 2004 Jun; 31(6):929-32. PubMed ID: 15222115
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
[TBL] [Abstract][Full Text] [Related]
34. [Clinical efficacy and safety of CPT-11+CDDP therapy as third-line chemotherapy for advanced and recurrent gastric cancer].
Godai TI; Oshima T; Numata M; Fukahori M; Sato T; Makino H; Fujii S; Rino Y; Masuda M; Imada T; Kunisaki C
Gan To Kagaku Ryoho; 2011 Jun; 38(6):945-9. PubMed ID: 21677484
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of low-dose CDDP and CPT-11 for patients with intestinal type of gastric adenocarcinoma].
Nagahori Y; Nagahori K; Hamaguchi Y; Fukushima T; Masui H; Mogaki M; Abe T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1555-9. PubMed ID: 18799911
[TBL] [Abstract][Full Text] [Related]
36. [A case report of bowel obstruction due to peritonitis carcinomatosa using combined administration with CPT-11 and CDDP].
Ohta K; Yoshida K; Tanabe K; Hihara J; Yamaguchi Y; Toge T
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1063-7. PubMed ID: 16044975
[TBL] [Abstract][Full Text] [Related]
37. A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer.
Kim SG; Oh SY; Kwon HC; Lee S; Kim JH; Kim SH; Kim HJ
Jpn J Clin Oncol; 2007 Oct; 37(10):744-9. PubMed ID: 17923456
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.
Park KW; Ahn JS; Park YS; Lee J; Kang JH; Park JO; Lim HY; Im YH; Kang WK; Park K; Lee SI
Cancer Chemother Pharmacol; 2007 Jan; 59(1):17-21. PubMed ID: 16721549
[TBL] [Abstract][Full Text] [Related]
39. Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
Sun Q; Liu C; Zhong H; Zhong B; Xu H; Shen W; Wang D
Jpn J Clin Oncol; 2009 Apr; 39(4):237-43. PubMed ID: 19264768
[TBL] [Abstract][Full Text] [Related]
40. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
